4.7 Article

Activation of non-canonical WNT signaling in human visceral adipose tissue contributes to local and systemic inflammation

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-017-17509-5

关键词

-

资金

  1. AHA Founders Affiliate Postdoctoral Grant [17POST32350003, 16POST27260178]
  2. AHA Scientist Development Grant [17SDG33400213]
  3. NIH [K23 HL135394, HL126141, HL131006, HL132564, HL081587, HL115391, HL102299, HL114675]

向作者/读者索取更多资源

The accumulation of visceral adiposity is strongly associated with systemic inflammation and increased cardiometabolic risk. WNT5A, a non-canonical WNT ligand, has been shown to promote adipose tissue inflammation and insulin resistance in animal studies. Among other non-canonical pathways, WNT5A activates planar cell polarity (PCP) signaling. The current study investigated the potential contribution of non-canonical WNT5A/PCP signaling to visceral adipose tissue (VAT) inflammation and associated metabolic dysfunction in individuals with obesity. VAT and subcutaneous adipose tissue (SAT) samples obtained from subjects undergoing bariatric surgery were analyzed by qRT-PCR for expression of WNT/PCP genes. In vitro experiments were conducted with preadipocytes isolated from VAT and SAT biopsies. The expression of 23 out of 33 PCP genes was enriched in VAT compared to SAT. Strong positive expression correlations of individual PCP genes were observed in VAT. WNT5A expression in VAT, but not in SAT, correlated with indexes of JNK signaling activity, IL6, waist-to-hip ratio and hsCRP. In vitro, WNT5A promoted the expression of IL6 in human preadipocytes. In conclusion, elevated non-canonical WNT5A signaling in VAT contributes to the exacerbated IL-6 production in this depot and the low-grade systemic inflammation typically associated with visceral adiposity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis

Maria A. Zuriaga, Jose J. Fuster

Summary: Accumulating evidence suggests that conventional cardiovascular risk factors are incomplete predictors of cardiovascular disease, as a substantial risk remains even when these factors are well-managed. Clonal hematopoiesis has emerged as a new and potent risk factor for atherosclerotic cardiovascular disease and other cardiometabolic conditions. However, the understanding of the epidemiology, biology, and clinical implications of this phenomenon remains incomplete.

CIRCULATION JOURNAL (2023)

Article Peripheral Vascular Disease

Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer

Maria A. Zuriaga, Jose J. Fuster

Summary: Despite current standards of care, there is still a significant risk of atherosclerotic cardiovascular disease in both primary and secondary prevention. Clonal hematopoiesis driven by somatic mutations has recently been identified as a common and independent risk factor for cardiovascular diseases. Experimental studies suggest that certain mutations in TET2 and JAK2 genes, which are frequently found in clonal hematopoiesis, contribute to inflammation and accelerated atherosclerosis development, providing a possible explanation for the increased cardiovascular risk. This review aims to provide an overview of our current understanding of this emerging cardiovascular risk factor.

CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS (2023)

Letter Cardiac & Cardiovascular Systems

E-Cigarette Use and Risk of Cardiovascular Disease: A Longitudinal Analysis of the PATH Study (2013-2019)

Jonathan B. Berlowitz, Wubin Xie, Alyssa F. Harlow, Naomi M. Hamburg, Michael J. Blaha, Aruni Bhatnagar, Emelia J. Benjamin, Andrew C. Stokes

CIRCULATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

Vascular Aging After COVID-19: A Story of Lasting Injury or Prolonged Healing?

Leili Behrooz, Jennifer E. Ho, Naomi M. Hamburg

CIRCULATION RESEARCH (2022)

Article Hematology

Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors

Jose J. Fuster

Summary: Somatic mutations are not only common in cancer, but also present in non-cancerous cells, particularly in the hematopoietic system. Clonal hematopoiesis, driven by certain mutations, is associated with a higher risk of hematological malignancies and may also contribute to the development of cardiovascular disease.

THROMBOSIS RESEARCH (2022)

Editorial Material Medicine, General & Internal

Troublemaking mutations: Clonal hematopoiesis for the prediction of prognosis in ST-segment elevation myocardial infarction

Miriam Diez-Diez, Jose J. Fuster

EBIOMEDICINE (2022)

Article Geriatrics & Gerontology

Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome

Miriam Diez-Diez, Marta Amoros-Perez, Jorge de la Barrera, Enrique Vazquez, Ana Quintas, Domingo A. Pascual-Figal, Ana Dopazo, Fatima Sanchez-Cabo, Monica E. Kleinman, Leslie B. Gordon, Valentin Fuster, Vicente Andres, Jose J. Fuster

Summary: Clonal hematopoiesis of indeterminate potential (CHIP), the presence of somatic mutations in cancer-related genes in blood cells without hematological cancer, is an important risk factor for age-related conditions, especially cardiovascular disease. It is unknown whether CHIP plays a role in premature aging syndromes. Hutchinson-Gilford progeria syndrome (HGPS) is an ultra-rare genetic condition characterized by accelerated aging. This study investigated the prevalence of CHIP in HGPS patients and found that it is not frequent in HGPS, suggesting that it is unlikely to contribute to the pathophysiology of this accelerated aging syndrome.

GEROSCIENCE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease One Step Closer to the Clinical Scenario

Jose J. Fuster, Benedetta Izzi

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Multidisciplinary Sciences

STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice

Susan MacLauchlan, Priyanka Kushwaha, Albert Tai, Sijia Chen, Catherine Manning, Gaurav Swarnkar, Yousef Abu-Amer, Katherine A. Fitzgerald, Shruti Sharma, Ellen M. Gravallese

Summary: Stimulator of interferon genes (STING) mediates interferon signaling and plays a crucial role in regulating homeostatic processes, including osteoclast differentiation and bone homeostasis. STING prevents trabecular bone loss in mice and influences osteoclast precursor differentiation through the regulation of interferon-stimulated genes (ISGs). These findings provide evidence for the important role of STING pathway in bone homeostasis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Cardiac & Cardiovascular Systems

Longitudinal Hemodynamic Correlates of and Sex Differences in the Evolution of Blood Pressure Across the Adult Lifespan: The Framingham Heart Study

Gary F. Mitchell, Jian Rong, Martin G. Larson, Leroy L. Cooper, Vanessa Xanthakis, Emelia J. Benjamin, Naomi M. Hamburg, Ramachandran S. Vasan

Summary: Systolic blood pressure increases with age after midlife, particularly in women, and contributes to development of wide pulse pressure hypertension in middle-aged and older adults. The relative contributions of aortic stiffness and premature wave reflection to increases in pulse pressure remain controversial.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cell Biology

Trends among platelet function, arterial calcium, and vascular function measures

Jason Cunha, Melissa V. Chan, Bongani B. Nkambule, Florian Thibord, Amber Lachapelle, Robin E. Pashek, Ramachandran S. Vasan, Jian Rong, Emelia J. Benjamin, Naomi M. Hamburg, Ming-Huei Chen, Gary F. Mitchell, Andrew D. Johnson

Summary: Arterial tonometry and vascular calcification measures are valuable in assessing cardiovascular disease (CVD) risk. This study examined the relationship between arterial tonometry, platelet function, arterial calcium, and aortic diameter. The results suggest that higher arterial calcium may be associated with increased platelet reactivity, while larger aortic diameter may be linked to lower platelet reactivity. These findings indicate the potential interplay between subclinical atherosclerosis, platelet activation, and vascular structure.

PLATELETS (2023)

Review Cardiac & Cardiovascular Systems

Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases

Leili Behrooz, Carrie G. Lenneman, Naomi M. Hamburg

Summary: This review discusses the impact of obesity on cardiovascular disease in women and the emerging anti-obesity pharmacologic treatments. The evidence shows that obesity burdens women across their lifespan and is linked to a variety of cardiovascular diseases. Female-specific risk factors, such as sex hormones and pregnancy factors, intersect with obesity and cardiovascular risk. Sustained weight loss has the potential for cardiovascular benefits. Recent trials demonstrate the cardiovascular benefits of emerging agents with weight loss effects, such as GLP-1 RA and SGLT2 inhibitors, in women.

CURRENT CARDIOLOGY REPORTS (2023)

Editorial Material Cardiac & Cardiovascular Systems

PCSK9-Inhibition to Quench Vascular Injury in Chronic Limb Threatening Ischemia

Ross Okazaki, Naomi M. Hamburg

JACC-BASIC TO TRANSLATIONAL SCIENCE (2023)

暂无数据